Article 1:Did the López-Medina Study in Cali Colombia Ivermectin Trial Include Protocol Deviations and 38 Switched Ivermectin and Placebo Doses?
Why did the mainstream media (e.g. CNN and New York Times) also pounce so fast on the story when so many positive trials have gone by without any interest? Critics of the positive result studies involving ivermectin have tossed indiscriminate criticism involving study design and study quality. Not surprisingly, none of the issues or concerns, including potential conflict of interest with direct pharmaceutical industry payments during the study raise even a word. And what about protocol violations in the study, including 38 switched ivermectin and placebo doses, failure of blinding and other considerations, such as the fact that there are widespread over the counter (OTC) ivermectin sales in the same city where the trial site is located. With nearly identical adverse events in both the ivermectin and control groups, just a number of questions mount. Why aren’t the experts out there critiquing this study? Is the Ivermectin finding in this case serving some underlying pecuniary interest?Link: Here
Referenced Link: Here
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).